Detail

Keywords

Anticoagulants; Critical Care; Extracorporeal Membrane Oxygenation; Hemodynamics; Intensive Care; Respiratory Distress Syndrome, Adult

Research interests

I am a clinician-scientist specialising in internal medicine and intensive care at the Department of Internal Medicine I, Intensive Care Unit 13i2. My research focuses mainly on clinical aspects of extracorporeal membrane oxygenation (ECMO), anticoagulation strategies and haemodynamic monitoring.

Techniques, methods & infrastructure

Bedside clinical studies and data science.

Selected publications

1. Nagler, B. et al. (2024) ‘Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis’, Journal of Thrombosis and Haemostasis, 22(10), pp. 2773–2783. Available at: https://doi.org/10.1016/j.jtha.2024.06.008.
2. Nagler, B. et al. (2024) ‘Comparison of Weaning Strategies in Patients Receiving Venovenous Extracorporeal Membrane Oxygenation: An Exploratory Retrospective Study’, ASAIO Journal, 70(11), pp. 987–993. Available at: https://doi.org/10.1097/mat.0000000000002223.
3. Nagler, B. et al. (2022) ‘Comparison of Hemostatic Changes in Pump-driven Extracorporeal Carbon Dioxide Removal and Venovenous Extracorporeal Membrane Oxygenation’, ASAIO Journal, 68(11), pp. 1407–1413. Available at: https://doi.org/10.1097/mat.0000000000001675.
4. Nagler, B. et al. (2021) ‘Incidence and Etiology of System Exchanges in Patients Receiving Extracorporeal Membrane Oxygenation’, ASAIO Journal, 67(7), pp. 776–784. Available at: https://doi.org/10.1097/mat.0000000000001332.
5. Buchtele, N. et al. (2022) ‘Add-On Prostaglandin E1 in Venovenous Extracorporeal Membrane Oxygenation: A Randomized, Double-Blind, Placebo-controlled Pilot Trial’, American Journal of Respiratory and Critical Care Medicine, 206(2), pp. 170–177. Available at: https://doi.org/10.1164/rccm.202110-2359oc.